AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 269: E683-E690, 1995;
0193-1849/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, J. P.
Right arrow Articles by Tannenbaum, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, J. P.
Right arrow Articles by Tannenbaum, G. S.

AJP - Endocrinology and Metabolism, Vol 269, Issue 4 E683-E690, Copyright © 1995 by American Physiological Society


ARTICLES

In vivo evidence of a positive role for somatostatin to optimize pulsatile growth hormone secretion

J. P. Turner and G. S. Tannenbaum
Department of Pediatrics, McGill University, Montreal, Quebec, Canada.

Despite convincing evidence that somatostatin (SRIF) and growth hormone (GH)-releasing factor (GRF) individually play crucial roles in GH regulation, the nature of the interplay between these two hypothalamic hormones is far from clear. In the present study, we used the long-acting SRIF analogue, octreotide, as a probe in both the normal and mutant dwarf (dw) rat 1) to further elucidate the temporal nature of the SRIF-GRF interaction in vivo and 2) to define possible mechanisms of action of SRIF in generating pulsatile GH secretion. Normal free-moving adult male rats pretreated with octreotide (25 and 50 micrograms iv) and subsequently challenged with GRF (1 micrograms iv) exhibited a markedly blunted GH response to exogenous GRF 1 h after treatment. In contrast, preexposure to octreotide for 3 h produced a two- to threefold augmentation in GH responsiveness to GRF. Compared with normal saline-pretreated controls, 3-h pretreatment with octreotide produced a 14- to 16-fold augmentation in the postinhibitory rebound release of GH after the coadministration of native SRIF-14 and GRF (P < 0.001). In dw rats, which show a selective reduction in GH synthesis and storage, 3-h preexposure to octreotide failed to significantly alter GRF-induced GH release. These results demonstrate that, in the normal male rat, a 3-h period of exposure to the SRIF analogue octreotide is sufficient to enhance GH responsiveness to GRF. Our findings suggest that this effect is due to a SRIF-mediated buildup of pituitary GH stores in a readily releasable poo.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
X. Wang, M. M. S. Chu, and A. O. L. Wong
Signaling mechanisms for {alpha}2-adrenergic inhibition of PACAP-induced growth hormone secretion and gene expression grass carp pituitary cells
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1750 - E1762.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. O. L. Wong, M. C. Y. Chuk, H. C. Chan, and E. K. Y. Lee
Mechanisms for gonadotropin-releasing hormone potentiation of growth hormone rebound following norepinephrine inhibition in goldfish pituitary cells
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E203 - E214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J.-C. Painson, J. D. Veldhuis, and G. S. Tannenbaum
Single exposure to testosterone in adulthood rapidly induces regularity in the growth hormone release process
Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E933 - E940.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. D. McMahon, L. T. Chapin, K. J. Lookingland, R. P. Radcliff, and H. A. Tucker
Feeding Reduces Activity of Growth Hormone-Releasing Hormone and Somatostatin Neurons
Experimental Biology and Medicine, February 1, 2000; 223(2): 210 - 217.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Beranek, I. Hajdu, J. Gardi, P. Taishi, F. Obal Jr., and J. M. Krueger
Central administration of the somatostatin analog octreotide induces captopril-insensitive sleep responses
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1999; 277(5): R1297 - R1304.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. R. Baumbach, T. A. Carrick, M. H. Pausch, B. Bingham, D. Carmignac, I. C. A. F. Robinson, R. Houghten, C. M. Eppler, L. A. Price, and J. R. Zysk
A Linear Hexapeptide Somatostatin Antagonist Blocks Somatostatin Activity In Vitro and Influences Growth Hormone Release in Rats
Mol. Pharmacol., November 1, 1998; 54(5): 864 - 873.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Gevers, S. M. Pincus, I. C. A. F. Robinson, and J. D. Veldhuis
Differential orderliness of the GH release process in castrate male and female rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R437 - R444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online